Skip to content

Development and clinical verification of a portable device for accurate resetting of otolithiasis

Development and clinical verification of a portable device for accurate resetting of otolithiasis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035696
Enrollment
Unknown
Registered
2020-08-16
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign paroxysmal positional vertigo

Interventions

BPPV group:Autonomous reset of rehabilitation equipment
Standard control group:Standard maneuver reset

Sponsors

Shanghai Sixth People's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Subjects who are over 18 years old and have no gender limit and can cooperate to complete the examination; (2) Subjects who are clearly diagnosed as unilateral benign paroxysmal positional vertigo (unilateral posterior semicircular canal BPPV or horizontal semicircular canal BPPV); (3) The subject or his legal representative can understand the purpose of the research, show sufficient compliance with the research protocol, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) The duration of the subject's benign paroxysmal positional vertigo attack was less than 3 days or more than 3 months; (2) The subject has severe cervical spine diseases, fractures, and traumatic brain injuries, such as those who do not allow physical activity, and acute attacks of vertigo caused by various causes; (3) Subjects have contraindications to the use of test products; (4) Subjects with serious cardiovascular and cerebrovascular diseases or organ failure; (5) Nursing women or pregnant women; (6) Subjects who have participated in any other drug or medical device clinical trials within the last 3 months; (7) Subjects that the investigator considers inappropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Reset treatment effect;

Countries

China

Contacts

Public ContactFeng Yanmei

Shanghai Sixth People's Hospital

feng.yanmei@126.com+86 021-24058706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026